Investors may be trying to decide if stocks will make new highs before the year is out, and whether or not the bull market will celebrate its 9th anniversary next year. The tricky part is prognosticating the short term picture. Investors may not be comfortable enough to go all in, but they may not want to get bearish given the solid economic backdrop. Will there be a big breakout given the strength of earnings and economic growth? Will investors just become numb to the headlines and decide to focus on the positive economic picture? It is always wise to remember that the market can have a correction at any time for any reason. If the political landscape gets even more dysfunctional, then it may be enough of a driver to spur a correction.
Following the Chaikin Money Flow indicator, we note that the current 20 day value is -0.36938727 on shares of Knight Therapeutics Inc. (ASX:GUD). Traders will watch to see if the indicator can help confirm an ongoing trend. In the midst of a bullish trend, the CMF value staying above zero may point to continuous buying pressure and the possibility of a sustained rise in price. In the midst of a bearish trend, the CMF value staying below zero may show continuous selling pressure and the possibility of continued price decline.
Trading on volume of 80000, Knight Therapeutics Inc. (ASX:GUD) has seen a change from the open of -0.09 since the stock opened at 7.67. Monitoring today’s activity, the stock has hit a high point of 7.67 and slipped to a low of 7.58.
Checking in on the Awesome Oscillator, we see that the reading is -0.10547059. Traders may follow this oscillator to measure market momentum. Created by Bill Williams, the Awesome Oscillator calculates the difference of the 5 period and 34 period SMA.
The 20 day Keltner Channels upper envelope is 7.7696276. The 20 day Keltner Channels lower envelope is 7.6310215. The Keltner Channels indicator was introduced by Chester Keltner in his book How to Make Money in Commodities. Keltner’s ideas have since been expanded upon and are widely used by technical traders.
Donchian Channels may be useful for technical traders. The primary function of the indicator is to measure volatility. The bands will widen when volatility is high, and they will become narrow with low volatility. The 20 day upper band level is 7.91. For the same period, the lower band level is 7.58.
Shares of Knight Therapeutics Inc. (ASX:GUD) ended last session at 7.58. Following today’s trade, we note that the stock has moved -1.0443864% since the opening bell. The company has a current market cap of 1094234900. The stock’s high price over the last month is presently 8.21.
Watching volatility readings, we can see the current value for the stock is 1.5831134. Volatility for the week stands at 1.1547363, and the monthly reading is 1.5430783. Volatility involves the amount of risk in relation to the amount of change in a stock’s value. Tracking the Bull Bear Power, we note that the stock is presently -0.09505723.
Scanning the equity market, we note that the stock’s current Oscillator Rating is showing “Neutral”. Traders will take note of many different factors when examining a stock’s health. Flipping over to the Moving Average Rating, we see that the current sentiment is pointing to a “Strong Sell”.
Investors might have been ready to throw in the towel as the rally stalled recently. However, the panic subsided and growth-hungry investors came searching for their favorite stocks in the wreckage. Keeping things in perspective, the economy seems good, and so does earnings growth. Investors may be wondering where the money will be flowing in the second half of the year. Many people may assume healthcare and tech would be the easy targets, primarily because that’s where the earnings growth is. Industrials and staples are no slouches for growth either, but they may be well fully-valued for their growth. Traders will most likely be honing their strategies that they created, trying to beat the market over the next couple of months.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.